The global cell therapy manufacturing market is poised for remarkable growth, with market size expected to reach USD 15,634.67 million by 2033, according to recent market projections. In 2023, the ...

The acquisition enhances ANI’s rare disease portfolio with a global ophthalmology franchise that should leverage ... to contribute significantly to ANI’s revenue, with pro forma sales estimated around ...

IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for the first ...

BRIDGEWATER, NJ and LONDON, UK / ACCESSWIRE / September 16, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the ...